MILLER RICHARD A MD has filed 7 insider transactions across 1 company since May 2024.
Most recent transaction: a grant/award of 1000000 shares of Corvus Pharmaceuticals, Inc. ($CRVS) on December 04, 2025.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 4, 2025 | Corvus Pharmaceuticals, Inc. | $CRVS | MILLER RICHARD A MD | President and CEO | A | Stock Option (Right to Buy) | 1000000 | $0.00 | 1,000,000.0000 | 82,836,369 | 9999.99% | 1.21% |
| May 7, 2025 | Corvus Pharmaceuticals, Inc. | $CRVS | MILLER RICHARD A MD | President and CEO | M | Warrant (Right to Buy) | 559073 | $0.00 | 0.0000 | 75,152,514 | 100.00% | 0.74% |
| May 7, 2025 | Corvus Pharmaceuticals, Inc. | $CRVS | MILLER RICHARD A MD | President and CEO | M | Common Stock | 559073 | $3.50 | 2,324,810.0000 | 75,152,514 | 31.66% | 0.74% |
| Dec. 20, 2024 | Corvus Pharmaceuticals, Inc. | $CRVS | MILLER RICHARD A MD | President and CEO | A | Stock Option (Right to Buy) | 750000 | $0.00 | 750,000.0000 | 66,701,086 | 9999.99% | 1.12% |
| May 10, 2024 | Corvus Pharmaceuticals, Inc. | $CRVS | MILLER RICHARD A MD | President and CEO | G | Common Stock | 302016 | $0.00 | 1,765,737.0000 | 49,038,582 | 14.61% | 0.62% |
| May 6, 2024 | Corvus Pharmaceuticals, Inc. | $CRVS | MILLER RICHARD A MD | President and CEO | P | Warrant (Right to Buy) | 559073 | $0.00 | 559,073.0000 | 49,038,582 | 9999.99% | 1.14% |
| May 6, 2024 | Corvus Pharmaceuticals, Inc. | $CRVS | MILLER RICHARD A MD | President and CEO | P | Common Stock | 577634 | $1.73 | 2,067,753.0000 | 49,038,582 | 38.76% | 1.18% |